ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 582

Rheumacheck – Spondyloarthritis: Comprehensive Fast-track Diagnosis Program. What Benefits Does It Offer in a Developing Country?

Einer Sanchez Prado1, Alvaro Ruta 2, Jessica Torres Chichande 2, Santiago Ruta 3, Sebastian Magri 2, Facundo Salvatori 2 and Rodrigo Garcia Salinas 2, 1Hospital Italiano de La Plata, La Plata, 2Hospital Italiano de La Plata, La plata, Buenos Aires, Argentina, 3Rheumatology Department, Hospital San Martín de La Plata and Rheumatology Unit, Hospital Italiano de La Plata, Argentina., La Plata, Argentina

Meeting: 2019 ACR/ARP Annual Meeting

Keywords: axial spondyloarthritis, diagnosis and Referrals, Psoriatic arthritis

  • Tweet
  • Email
  • Print
Session Information

Date: Sunday, November 10, 2019

Title: Spondyloarthritis Including Psoriatic Arthritis – Clinical Poster I: Axial Spondyloarthritis, Clinical Features

Session Type: Poster Session (Sunday)

Session Time: 9:00AM-11:00AM

Background/Purpose: In our region, the lack of knowledge, timely referral and access to laboratory tests and images are the main causes in the diagnostic delay of spondyloarthritis (SpA), which is estimated between 6 and 10 years. Objectives: To evaluate the delay between the onset of symptoms, referral and access to the fast-track diagnosis program. To compare the differential characteristics in patients with axial symptoms.

Methods: Patients older than 18 years who entered a Rheumacheck-SpA were included according to the following criteria: peripheral arthritis plus at least one SpA feature (ASAS 2006) or low back pain of 3 months of evolution that began before 45. Patients were perfomored at the same day: blood analysis with acute phase reactants, HLA B27 (low back pain), sacroiliac X-r, sacroiliac MRI, joint and entheses ultrasonography (regardless of symptoms), sociodemographic data , characteristics of the disease (eg: age of onset), clinimetry and treatments. The symptom evaluator was unaware of the results of the complementary studies that were collected by another observer. Previously, a plan of awareness was made to the local community, physicians and health personnel involved (media campaigns, social networks and referral talks). Statistical analysis: descriptive statistics were carried out and, Chi2 and Fisher’s exact test (categorical variables) and Student’s Test or Mann Whitney (continuous variables) were applied.

Results: 135 patients entered the fast-track diagnosis program for 18 months, 99 with axial symptoms and 36 with peripheral symptoms. 53% female, average age 45.5 yrs (11.3), 74% were employed. SpA feature 40% (77% psoriasis, 10% uveitis, 3% IBD), SpA family history  26% (70% psoriasis, 15% SpA, 10% IBD). Of the patients with peripheral symptoms, 100% met criteria for psoriatic arthritis; and patients with axial symptoms 47.5% (95% CI 33-58) met ASAS criteria for axial SpA. Median delay since symptoms began at diagnosis were 37.7 months (RIC 12-85). Those patients referred by specialists (orthopedics-Dherm) had a delay of  0.75 months (RIC: 0.55-1.3). 25% of patients with a diagnosis were referred after the awareness campaign and 55% attended because saw the social media ads. Table 1 shows the differences between patients.

Conclusion: The delay from the onset of symptoms and access to the program (final diagnosis) was 3 years, and the delay of referral by another specialist was less than one month, 70% attended after the awareness campaign. Patients with axial SpA diagnoses had distinctive clinical, laboratory and imaging characteristics.


Disclosure: E. Sanchez Prado, None; A. Ruta, None; J. Torres Chichande, None; S. Ruta, None; S. Magri, None; F. Salvatori, None; R. Garcia Salinas, None.

To cite this abstract in AMA style:

Sanchez Prado E, Ruta A, Torres Chichande J, Ruta S, Magri S, Salvatori F, Garcia Salinas R. Rheumacheck – Spondyloarthritis: Comprehensive Fast-track Diagnosis Program. What Benefits Does It Offer in a Developing Country? [abstract]. Arthritis Rheumatol. 2019; 71 (suppl 10). https://acrabstracts.org/abstract/rheumacheck-spondyloarthritis-comprehensive-fast-track-diagnosis-program-what-benefits-does-it-offer-in-a-developing-country/. Accessed .
  • Tweet
  • Email
  • Print

« Back to 2019 ACR/ARP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/rheumacheck-spondyloarthritis-comprehensive-fast-track-diagnosis-program-what-benefits-does-it-offer-in-a-developing-country/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology